Loading clinical trials...
Loading clinical trials...
A Multicenter, Prospective, Controlled, Longitudinal-Cohort Study Assessing the Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)
Conditions
Interventions
Omegaven® (fish oil triglycerides) Injectable Emulsion
Start Date
April 1, 2022
Primary Completion Date
May 1, 2028
Completion Date
May 1, 2029
Last Updated
August 4, 2022
NCT06049680
NCT06274788
NCT05181085
NCT05347888
NCT00826020
NCT05377008
Lead Sponsor
Fresenius Kabi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions